Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human...

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Genomics and Bioinformatics

Background:

• Type 2 Diabetes (T2D) is characterized by progressive islet dysfunction.
• Understanding the molecular mechanisms underlying T2D pathogenesis is crucial for developing effective therapies.
• Existing research is limited by the availability of comprehensive human pancreatic tissue data.

Purpose of the Study:

• To provide an overview of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D).
• To highlight the program's goal of defining the molecular pathogenesis of islet dysfunction in T2D.
• To emphasize the creation of a centralized, freely accessible data resource for the research community.

Main Methods:

• Utilizes human pancreatic tissue samples from organ donors with T2D.
• Generates multi-omic datasets including physiological, histological, transcriptomic, epigenomic, and genomic information.
• Establishes a centralized database (PANC-DB) for data dissemination.

Main Results:

• HPAP-T2D systematically collects and analyzes diverse molecular and histological data from human pancreatic tissues.
• The program ensures immediate and free availability of all generated data.
• PANC-DB serves as a comprehensive resource for T2D research.

Conclusions:

• HPAP-T2D is a significant initiative providing invaluable data for understanding T2D.
• The program's open-access data policy accelerates research into islet dysfunction.
• PANC-DB empowers the diabetes research community with detailed molecular insights into T2D pathogenesis.